Eating Disorders Clinical Research Network (EDCRN)

August 2, 2024 updated by: King's College London

UK Eating Disorder services are facing unprecedented demand, with effective service delivery hampered by inadequate resources, fragmented services and variable care pathways. Individuals with eating disorders, families and clinicians all agree on the critical need to improve care pathways and treatment, leading to better outcomes.

Eating disorders are serious, complex conditions influenced by a blend of biological, psychological, and environmental factors. The approach of this project is grounded in the "biopsychosocial" model. Recently, anorexia research confirms a genetic component, with biological, metabolic, and psychological mechanisms at play. Further biological research across eating disorders could allow a better understanding of the mechanisms underlying eating disorder development and better, more personalised treatments.

This project will test the feasibility of establishing a UK-wide NHS research network spanning child and adult eating disorder services to enable a step change in the ability to conduct eating disorder research. It will help address fragmentation and facilitate novel biological, psychological, and social research collaborations. The data the investigators gather will be open to all researchers for data analyses, and the collaborations established will form a collaborative network to enable future clinical trials, experimental medicine and psychology.

The study will be conducted at child and adult eating disorder services who opt to join the Network. Participants will be patients receiving treatment for an eating disorder at one of the participating services, and their parents/guardians if applicable.

Participants will complete questionnaires and have blood and other physical tests as specified in the EDCRN dataset. The study will last until 29th October 2026 (the end of the current funding period) and/or when a participant is discharged from treatment, whichever is sooner. For participants discharged before the study ends, there will be an opportunity for patients to complete optional follow-up questionnaires on a periodic basis.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

12000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

The study population are individuals who are receiving treatment for an eating disorder(s) at a UK-based eating disorder service which is part of the EDCRN and (if desired by the patient and caregiver) their parents/guardians.

Description

Inclusion Criteria:

  • Patients who have been diagnosed with an eating disorder under at least 1 of the criteria specified in the DSM-5 and/or ICD-9, 10 or 11.
  • Patients who are receiving treatment as inpatients, day-patients or outpatients at a CAMHS or Adult service who is participating in the EDCRN.
  • Patients who are receiving treatment in the UK.

OR:

  • Parents/guardians of patients who have been diagnosed with an eating disorder under at least 1 of the criteria specified in the DSM-5 and/or ICD-9, 10 or 11.
  • Parents/guardians of patients who are receiving treatment as inpatients, day-patients or outpatients at a CAMHS or Adult service who is participating in the EDCRN.
  • Parents/guardians of patients who are receiving treatment in the UK.

Exclusion Criteria:

  • Individuals who do not meet the criteria specified above will be considered ineligible to participate in the EDCRN.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EDCRN dataset
Time Frame: 29th October 2026

The existence of a well-described dataset (maintained by at >50% eating disorder services across the UK) of eating disorder presentation, treatment, outcomes, demographics, social risk factors, and blood test results which can be accessed (with appropriate permissions) by researchers and others for the purposes of addressing novel research questions and facilitating service improvement efforts.

The EDCRN dataset comprises the following parameters:

  • ED Behaviours/cognitions
  • Depression
  • Anxiety
  • Autism
  • OCD
  • Perfectionism
  • Emotional regulation
  • Psychosocial impairment
  • Adverse experiences
  • Self-injurious behaviour
  • Food insecurity
  • Physical/somatic symptoms
  • ADHD
  • Alcohol use
  • PTSD symptoms
  • Self-administered comorbidity
  • Weight stigma
  • Treatment experience
  • Comorbidities
  • Caregiver impact
  • Weight history
  • Muscle power
  • Endocrine function
  • Liver function
  • Cardiac function
  • Electrolytes
  • Bone health
  • Demographics
29th October 2026

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Data on treatment effects
Time Frame: 29th October 2026
Data which provides insights into treatment moderators and mediators for different demographic groups.
29th October 2026
Genetic Biomarkers
Time Frame: 29th October 2026
Indicators of genetic biomarkers of treatment response.
29th October 2026
Socio-economic influences
Time Frame: 29th October 2026
Data which indicates socio-economic factors (e.g. the local food environment) influencing ED development, maintenance and outcomes.
29th October 2026

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gerome Breen, PhD, King's College London (KCL)
  • Principal Investigator: Karina Allen, PhD, South London and Maudsley NHS Foundation Trust (SLaM)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2024

Primary Completion (Estimated)

October 29, 2026

Study Completion (Estimated)

October 29, 2026

Study Registration Dates

First Submitted

July 23, 2024

First Submitted That Met QC Criteria

August 2, 2024

First Posted (Estimated)

August 5, 2024

Study Record Updates

Last Update Posted (Estimated)

August 5, 2024

Last Update Submitted That Met QC Criteria

August 2, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RE22072
  • MR/X030539/1 (Other Grant/Funding Number: Medical Research Council)
  • 341570 (Other Identifier: Health Research Authority)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eating Disorders

Clinical Trials on EDCRN questionnaires

Subscribe